C
Chenxi Liu
Researcher at Peking Union Medical College Hospital
Publications - 29
Citations - 498
Chenxi Liu is an academic researcher from Peking Union Medical College Hospital. The author has contributed to research in topics: Autoantibody & Dermatomyositis. The author has an hindex of 7, co-authored 27 publications receiving 194 citations.
Papers
More filters
Journal ArticleDOI
Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Linlin Cheng,Haolong Li,Liubing Li,Chenxi Liu,Songxin Yan,Haizhen Chen,Haizhen Chen,Yongzhe Li +7 more
TL;DR: The aim of this study was to determine the role of ferritin in COVID‐19, a pandemic coronavirus disease that has rapidly developed into aPandemic.
Journal ArticleDOI
Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression
Haoting Zhan,Haizhen Chen,Haizhen Chen,Chenxi Liu,Linlin Cheng,Songxin Yan,Haolong Li,Yongzhe Li +7 more
TL;DR: D-dimer shows high sensitivity but relatively low specificity for detecting COVID-19-related VTE events, indicating that it can be used to screen for patients with VTE and can predict severe and fatal cases of CO VID-19 with moderate accuracy.
Journal ArticleDOI
Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis.
Liubing Li,Qian Wang,Funing Yang,Funing Yang,Chanyuan Wu,Si Chen,Si Chen,Xiaoting Wen,Chenxi Liu,Yongzhe Li +9 more
TL;DR: It is suggested that anti-MDA5 antibodies correlate with DM and could be used as a biomarker in the clinical diagnosis of CADM, and was found to be significantly associated with an increased risk of death in DM.
Journal ArticleDOI
Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease.
Liubing Li,Qian Wang,Xiaoting Wen,Chenxi Liu,Chanyuan Wu,Funing Yang,Funing Yang,Xiaofeng Zeng,Yongzhe Li +8 more
TL;DR: It is suggested that anti-MDA5 antibody has a potential useful ability as a noninvasive biomarker in the diagnosis of RPILD in patients with DM.
Journal ArticleDOI
Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease.
Liubing Li,Han Wang,Qian Wang,Chanyuan Wu,Chenxi Liu,Yanfang Zhang,Linlin Cheng,Xiaofeng Zeng,Fengchun Zhang,Yongzhe Li +9 more
TL;DR: MSAs and MAAs serve as biomarkers for differentiatingDM/PM from other CTDs as well as distinguishing DM/PM with ILD from DM/ PM without ILD.